Agenda

Agenda

May 3, 2026 | 5:30 – 10:00 PM

5:30 PM – Registration, Exhibits and Welcome Reception

Session 1

6:00 PM – Opening Remarks

6:02 PM – Is There a Role for Photobiomodulation in Non-neovascular AMD – Hong-Uyen Hua, MD
6:10 PM – What’s Next in AMD and GA Therapy – Dilraj Grewal, MD
6:18 PM – Gene Therapy for AMD – Katherine Talcott, MD
6:26 PM – Integrating AI Insights into Clinical Workflow: From Imaging to Intervention – Justis Ehlers, MD
6:34 PM – Dual Mechanism Versus High-Dose Anti-VEGF Treatment for AMD, DME, and RVO: Real World Data – Rishi Singh, MD
6:42 PM – Updates in Ocular Oncology – Prithvi Mruthyunjaya, MD, MHS
6:50 PM – Break and Exhibits
7:05 PM – Innovation in the Operating Room – Sumit Sharma, MD
7:13 PM – Panel Discussion: Surgical Cases – Course Directors + All Faculty

Session 2 

7:28 PM – Navigating Access, Cost, and Real-World Adoption Barriers – Avni Finn, MD, MBA
7:36 PM – Update on Tyrosine Kinase Inhibitors – Abdul-Hadi Kaakour, MD
7:44 PM – Retinal Findings in Cardiovascular Disease – Sunil Srivastava, MD
7:52 PM – Uveitis Masquerades – Phoebe Lin, MD, PhD
8:00 PM – Break and Exhibits
8:15 PM – Clinical Features and Retina Detachment Rates in Patients with Genetically Confirmed Knobloch Syndrome: A Multi-Center US Based Case Review – Prethy Rao, MD
8:23 PM – IRD Updates – Thomas Mendel, MD
8:31 PM – Update on Mactel, Trials and Treatment – Alex Yuan, MD, PhD
8:39 PM – Panel Discussion: Medical Cases – Course Directors + All Faculty
8:54 PM – Program Concludes – Course Directors
9:00 PM – Fellows Panel & Reception – Course Directors